The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery

Vaccine

Volumn 24, Issue SUPPL. 2, 2006, Pages S7-S10

  Davis, Stanley S ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Chitosan; Microspheres; Nasal

Indexed keywords

ANTIGEN; BIOPOLYMER; CHITOSAN; DIPHTHERIA TOXIN; DIPHTHERIA VACCINE; DNA; HEMAGGLUTININ; INFLUENZA VACCINE; MICROSPHERE; NUCLEOPROTEIN; POLYGLACTIN; POLYLACTIDE; POLYMER; TRIPLE VACCINE; VACCINE;

ARTICLE; BIODEGRADATION; DRUG DELIVERY SYSTEM; EXPERIMENTAL MODEL; HUMAN; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VACCINE PRODUCTION;

EID: 33645228369     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.01.102     Document Type: Article

References (12)

1. H. Okada One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate Adv Drug Deliv Rev 28 1 1997 43 70
2. D.T. O'Hagan, H. Jeffery, M.J. Roberts, J.P. McGee, and S.S. Davis Controlled release microparticles for vaccine development Vaccine 9 10 1991 768 771
3. M.K. Yeh, S.S. Davis, and A.G. Coombes Improving protein delivery from microparticles using blends of poly(dl lactide co-glycolide) and poly(ethylene oxide)-poly(propylene oxide)copolymers Pharm Res 13 11 1996 1693 1698
4. M. Yeh, and C. Chiang Inactive Vibrio cholerae whole-cell vaccine-loaded biodegradable microparticles: in vitro release and oral vaccination J Microencapsul 21 1 2004 91 106
5. I. Jabbal-Gill, W. Lin, P. Jenkins, P. Watts, M. Jimenez, and L. Illum Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines Vaccine 18 3-4 1999 238 250
6. N. Venkataprasad, A.G. Coombes, M. Singh, M. Rohde, K. Wilkinson, and F. Hudecz Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers Vaccine 17 15-16 1999 1814 1819
7. I.I. Wilding, P. Hirst, and A. Connor Development of a new engineering-based capsule for human drug absorption studies Pharm Sci Technol Today 3 11 2000 385 392
8. M. Mutsch, W. Zhou, P. Rhodes, M. Bopp, R.T. Chen, and T. Linder Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland N Engl J Med 350 9 2004 896 903
9. L. Illum Chitosan and its use as a pharmaceutical excipient Pharm Res 15 9 1998 1326 1331
10. L. Illum, I. Jabbal-Gill, M. Hinchcliffe, A.N. Fisher, and S.S. Davis Chitosan as a novel nasal delivery system for vaccines Adv Drug Deliv Rev 51 13 2001 81 96
11. K.H. Mills, C. Cosgrove, E.A. McNeela, A. Sexton, R. Giemza, and I. Jabbal-Gill Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin A Infect Immun 71 2 2003 726 732
12. M. Iqbal, W. Lin, I. Jabbal-Gill, S.S. Davis, M.W. Steward, and L. Illum Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice Vaccine 21 13-14 2003 1478 1485